G vs. MRK
Compare and contrast key facts about Genpact Limited (G) and Merck & Co., Inc. (MRK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: G or MRK.
Correlation
The correlation between G and MRK is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
G vs. MRK - Performance Comparison
Loading data...
Key characteristics
G:
0.90
MRK:
-1.46
G:
1.58
MRK:
-1.97
G:
1.25
MRK:
0.74
G:
0.79
MRK:
-0.90
G:
4.42
MRK:
-1.67
G:
7.18%
MRK:
23.41%
G:
33.84%
MRK:
27.67%
G:
-64.14%
MRK:
-68.62%
G:
-20.17%
MRK:
-41.45%
Fundamentals
G:
$7.67B
MRK:
$187.83B
G:
$2.98
MRK:
$7.00
G:
14.72
MRK:
10.69
G:
1.70
MRK:
0.69
G:
1.58
MRK:
2.94
G:
3.13
MRK:
3.89
G:
$4.85B
MRK:
$63.92B
G:
$1.71B
MRK:
$51.75B
G:
$834.55M
MRK:
$27.30B
Returns By Period
In the year-to-date period, G achieves a 3.24% return, which is significantly higher than MRK's -22.88% return. Over the past 10 years, G has outperformed MRK with an annualized return of 7.62%, while MRK has yielded a comparatively lower 6.00% annualized return.
G
3.24%
-7.42%
-0.67%
30.32%
7.55%
7.62%
MRK
-22.88%
-0.52%
-19.71%
-40.16%
3.11%
6.00%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
G vs. MRK — Risk-Adjusted Performance Rank
G
MRK
G vs. MRK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Genpact Limited (G) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
G vs. MRK - Dividend Comparison
G's dividend yield for the trailing twelve months is around 1.42%, less than MRK's 4.15% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
G Genpact Limited | 1.42% | 1.42% | 1.59% | 1.08% | 0.81% | 0.95% | 0.81% | 1.11% | 0.76% | 0.00% | 0.00% | 0.00% |
MRK Merck & Co., Inc. | 4.15% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% | 3.12% |
Drawdowns
G vs. MRK - Drawdown Comparison
The maximum G drawdown since its inception was -64.14%, smaller than the maximum MRK drawdown of -68.62%. Use the drawdown chart below to compare losses from any high point for G and MRK. For additional features, visit the drawdowns tool.
Loading data...
Volatility
G vs. MRK - Volatility Comparison
Genpact Limited (G) has a higher volatility of 17.75% compared to Merck & Co., Inc. (MRK) at 12.13%. This indicates that G's price experiences larger fluctuations and is considered to be riskier than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
G vs. MRK - Financials Comparison
This section allows you to compare key financial metrics between Genpact Limited and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
G vs. MRK - Profitability Comparison
G - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Genpact Limited reported a gross profit of 428.99M and revenue of 1.21B. Therefore, the gross margin over that period was 35.3%.
MRK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported a gross profit of 12.11B and revenue of 15.53B. Therefore, the gross margin over that period was 78.0%.
G - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Genpact Limited reported an operating income of 183.70M and revenue of 1.21B, resulting in an operating margin of 15.1%.
MRK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported an operating income of 5.94B and revenue of 15.53B, resulting in an operating margin of 38.2%.
G - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Genpact Limited reported a net income of 130.85M and revenue of 1.21B, resulting in a net margin of 10.8%.
MRK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Merck & Co., Inc. reported a net income of 5.08B and revenue of 15.53B, resulting in a net margin of 32.7%.